PharmaKB logo
Company Reports
Company Reports
Drug Reports
Drug Reports
Disease Reports
Disease Reports
AboutPricing
Disease ReportsThrombocytopenic purpura idiopathic
MeSH D016553 - thrombocytopenic purpura idiopathic
Favorite
Competitive Landscape
Events Timeline
Commercial
Clinical Trials
Competitive landscape
D011696:Thrombocytopenic purpura
$
Success rate
D001327:Autoimmune diseases
$
Success rate
D006474:Hemorrhagic disorders
$
Success rate
D016553: 
Thrombocytopenic purpura idiopathic
Events Timeline
Loading
Commercial
Company Name
Drug Name
Trade Name
Patent Expires
Approval Date
Revenue
Period
A.H. Robins CompanyCortisone Cortisone  1982-01-01   
Prednisone Prednisone  1982-01-01   
AAIPharmaAzathioprine Azasan  1999-06-07   
AbbVieDexamethasone Ozurdex 2023-01-09 2009-06-17 $488 M Q2/23-Q1/24 
Alcon ResearchDexamethasone Maxidex  1982-01-01   
Dexamethasone, Neomycin, Polymyxin b Neomycin Polymyxin B Sulfates Dexamethasone  1986-11-17   
Dexamethasone, Neomycin Neomycin Sulfate-dexamethasone  1986-07-21   
Alembic PharmaceuticalsCyclophosphamide Cyclophosphamide  2022-11-10   
Alkem LaboratoriesAzathioprine Azathioprine  2020-03-27   
AllerganDexamethasone Aeroseb-dex  1982-01-01   
Cortisone Cortisone  1982-01-01   
Dexamethasone Dexamethasone  1982-01-01   
Prednisone Prednisone  1982-01-01   
AlpharmaDexamethasone Dexamethasone  1986-10-10   
AlvogenDexamethasone Dexamethasone  1983-04-28   
American TherapeuticsPrednisone Prednisone  1986-11-06   
1
2
3
4
5
6
...
11
>
Clinical Trials
Historical Success Rate
Phase 1
67%
16/24
Phase 2
59%
23/39
Phase 3
63%
27/43
Approved: 12Overall Success rate: 25%
All Clinical Trials
Therapeutic Areas:
All
Classification:
All
Approval:
All
Status:
All
Phases:
All
Company name
Phase 1
Phase 2
Phase 3
Phase 4
Drug Name
AbbVie
Allergan
1
2
3
4
5
6
7
>
© 2020-2023 Collaborative Drug Discovery Inc. (CDD) | Terms of Use